BIOTECH: SAN DIEGO

TABLE OF CONTENTS

– Vividion Therapeutics, a company that was acquired for $1.5 billion and $500,000 in biobucks three years ago by Bayer, is expanding its local presence with a brand-new headquarters and R&D center.

Read latest San Diego Business Journal online.

Online newspapers at PressDisplay.